Skip to main content
. 2021 Jan 27;156(3):e206363. doi: 10.1001/jamasurg.2020.6363

Figure 3. Effect Size of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) on Short-term Surgical Outcomes According to Subsets and Drug Combinations.

Figure 3.

Data are presented as weighted odds ratios (ORs) of unfavorable surgical outcomes from multivariable logistic models and bootstrap 95% CI for patients treated with HIPEC. Morbidity is determined by grades 3 to 5 in the National Cancer Institute Common Terminology for Adverse Events, version 3.0. Arrow indicates width of 95% CI extends beyond boundary of the graph. CRS indicates cytoreductive surgery.